News Conference News STS 2025 Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis Yael L. Maxwell February 05, 2025
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News AHA 2019 AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials Shelley Wood November 11, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News ACC 2017 Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery Michael O'Riordan March 19, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News CRT 2017 Pressure Wire Helps Identify Severe Aortic Stenosis in Paradoxical Low-Flow/Low-Gradient Cases Michael O'Riordan February 21, 2017
News Conference News TVT 2016 Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY Michael O'Riordan June 18, 2016
News Conference News EuroPCR 2016 Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up Shelley Wood May 20, 2016
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details Caitlin E. Cox April 08, 2011
News Conference News PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective Caitlin E. Cox April 03, 2011